Borja AVH, Grajales MC, González LM, Mejia AJM

Language: Spanish
References: 25
Page: 303-310
PDF size: 85.02 Kb.

ABSTRACT

Introduction: The purpose of this study is to estimate the burden of the disease associated to pandemic 2009 influenza virus, from April 2009 to January 2010. Methods: To estimate the number of symptomatic cases, the number of hospitalizations and deaths we used the Center for Disease Control (CDC) recommended method that takes into account the underestimation associated with the use of health services, the practices of confirmation and registration of cases. To estimate the incidence of infection, we applied the recently reported London sero-incidence by age group to the IMSS population. Results: Each case of symptomatic confirmed influenza represented 51 cases during the first wave and 18 in the second wave. We estimate 537,167 (range 378,439-813,008) symptomatic cases. Each confirmed hospitalized person represented 2.2 cases. The estimate of hospitalizations was 10,063 (range 7,441-14,610). The ratio of hospitalization to the total number of cases was 1.8%. The estimated incidence of infection was close to 24%. Conclusions: Confirmed cases in the epidemiological surveillance system are only a small proportion of the population infected and symptomatic cases, information relevant in planning new outbreaks.

REFERENCES

1. Pandemic Influenza Outbreak Research Modelling Team (Pan-InfORM). Modelling an influenza pandemic: a guide for the perplexed. CMAJ. 2009;181:171-3.

2. Garske T, Legrand J, Donnelly CA, et al. Assessing the severity of the novel influenza A/H1N1 pandemic. BMJ. 2009:339:220-4.

3. Ghani AC, Donnelly CA, Cox DR, et al. Methods for estimating the case fatality ratio for a novel, emerging infectious disease. Am J Epidemiol. 2005;162:479-86.

4. Lipsitch M, Lajous M, O’Hagan JJ, et al. Use of cumulative incidence of novel influenza A/H1N1 in foreign travelers to estimate lower bounds on cumulative incidence in Mexico. PLoS One 2009;4(9):e6895.

5. Towers S, Feng Z. Pandemic H1N1 influenza: Predicting the course of a pandemic and assessing the efficacy of the planned vaccination programme in the United States. Euro Surveill. 2009;14(41):19358.

6. Reed C, Angulo FJ, Swerdlow DL, et al. Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerg Infect Dis [Internet]. 2009 Dec [28 de febrero de 2010]. Available from: http://www.cdc.gov/EID/content/15/12/2004.htm. OI: 10.3201/eid1512.091413

7. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351:2611-8.

8. Bell DM, Weisfuse IB, Hernández-Ávila M, Del Río C, Bustamante X, Rodier G. Pandemic influenza as 21st century urban public health crisis. Emerg Infect Dis. 2009;15:1962-9.

9. Echevarría-Zuno S, Mejía-Aranguré JM, Mar-Obeso AJ, et al. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analisis. Lancet. 2009;374:2072-9.

10. Dirección General Adjunta de Epidemiología. Secretaría de Salud. Estimación de casos de enfermedad tipo influenza/infección respiratoria aguda grave (ETI/IRAG) en México, 2009. Boletín Influenza en México, temporada otoño-invierno 2009-2010. Número 11. México, D.F.: Secretaría de Salud; 2010. p. 4-5.

11. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet. 2010;375:1100-8.

12. Centers for Disease Control and Prevention. CDC estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States, April 2009-January 16, 2010.

13. Instituto Mexicano del Seguro Social. Encuesta nacional de Coberturas, 2006. IMSS, México, D.F. 2006.

14. Health Protection Agency. Method used to estimate new pandemic (H1N1) 2009 influenza cases in England in the week 3 August to 9 August 2009. [Internet]. Available from: http:/www.hpa.org.uk/web/HPAwebfile/HPAweb_C/1250150839845 (consultado el 26 de febrero de 2010).

15. Flusurvey. UK flu surveillance. [Internet]. Available from: http:/www.flusurvey.co.uk (consultado el 26 de febrero de 2010).

16. SINOLAVE. [Internet]. Available from: http://11.254.16.224/Influenza2009_v1.4/ (consultado el 26 de febrero de 2010).

17. Health Protection Agency. Weekly National Influenza Report. Week 08 2010. [Internet]. Available from: http://www.hpa.org.uk/web/HPAweb&Page&HPAwebAutoListName/Page/1243928258560 (consultado el 26 de febrero de 2010).

18. Chowell G, Echevarría-Zuno S, Viboud C, et al. Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico. PLoS Med. 2011;8(5) e1000436. doi:10.1371/journal.pmed.1000436

19. Ross T, Zimmer S, Burke D, et al. Seroprevalence following the second wave of pandemic 2009 H1N1 influenza. PLoS Curr Influenza. 2010:RRN1148.

20. Donaldson LJ, Rutter PD, Ellis BM, et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. Brit Med J. 2009;339:b5213.

21. Hancock K, Veguilla V, Lu X, et al. Cross reactive antibody respoences to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009; 361:1945-52.

22. Fisman DN, Savage R, Gubbay J, et al. Older age and a reduced likelihood of 2009 H1N1 virus infection. N Engl J Med. 2009;361:2000-1.

23. Castilla J, Etxeberria J, Ardanaz E, Floristan Y, López Escudero R, Guevara M. Estimating the impact of the 2009 influenza A(H1N1) pandemic on mortality in the elderly in Navarre, Spain. Euro Surveill. [Internet]. 2010;15(5):pii=19481. Available from: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=19481

24. Echevarría-Zuno S, Mejía-Aranguré JM, Grajales-Muñiz C, González-Bonilla C, Borja-Aburto VH. Seasonal vaccine effectiveness against pandemic A/H1N1[letter]. Lancet. 2010;375:802-3.

25. Instituto Mexicano del Seguro Social. Estadísticas en Salud. [Internet]. Available from: http://www.imss.gob.mx/dpm/dties/ (consultado el 26 de febrero de 2010).